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The extract of Alpinia katsumadai, a member of the family Zingiberaceae, shows anti-inflammatory effects
and antioxidant activity. We observed the neuroprotective effects of the extract from Alpinia katsumadai
seed (EAKS) against ischemic damage in gerbils administered oral EAKS (25, and 50 mg/kg) once a day for
7 days before transient cerebral ischemia. In the 50 mg/kg EAKS-treated ischemia group, about 67% of
neurons in the hippocampal CA1 region (CA1) survived after ischemia/reperfusion (I/R) based on cresyl
violet staining. We observed that EAKS treatment significantly maintained brain-derived neurotrophic
factor (BDNF) immunoreactivity in the ischemic CA1 region after I/R. In addition, protein levels of BDNF
in the 50 mg/kg EAKS-treated ischemia group were much higher than those in the vehicle-treated
ischemia group after I/R. These findings indicate that repeated supplementation of EAKS protects neurons
from ischemic damage, such that BDNF is distinctively maintained in ischemic areas.
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Alpinia katsumadai is a member of the family Zingiberaceae
that has been used for traditional Chinese medicine. This
plant contains the following compounds: chalcone, flavonoids,
diarylheptanoids, monoterpenes, sesquiterpenoids, stilbenes
and labdanes (Saiki et al, 1978; Kuroyanagi et al, 1983; Yang
et al, 1999). The extract of Alpinia katsumadai seed (EAKS)
suppressed topical pruritis, showed anti-inflammatory effects,
and enhanced antioxidant activity in several studies (Lee et
al, 2003; Choi et al, 2009b). Hua et al (2009) also reported
that EAKS has potent cytotoxic activity against the HepG2,
MCF-7 and MAD-MB-435 cell lines.
Transient cerebral ischemia is known to result in neuronal
death in some specific vulnerable regions such as the
hippocampus, neocortex and striatum (Kirino, 1994). The
Mongolian gerbil has been widely used as a model of transient
cerebral ischemia, because the animal does not have a
complete Willis’ circle. Therefore, in this study, we investigated
the neuroprotective effects of EAKS against delayed neuronal
death in the hippocampal CA1 region using gerbils.
Materials and Methods
Alpinia katsumadai seeds were collected in Kangwon
Province, Korea. The method of preparation of EAKS was
reported previously by Hwang et al (2004). Briefly, for the
preparation of ethanol EAKS, Alpinia katsumadai seeds were
dried and ground into fine powder. The powder was dispersed
in 75% ethanol and refluxed for 1 hour at 50
oC. This extraction
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procedure was repeated three times. The ethanol extract was
dried under vacuum.
Male Mongolian gerbils (6 months of age) were obtained
from the Experimental Animal Center, Hallym University,
Chuncheon, Korea. The procedures for handling animals and
their care conformed to guidelines compliant with current
international laws and policies (NIH Guide for the Care and
Use of Laboratory Animals, NIH Publication No. 85-23, 1985,
revised 1996). 
The animals were divided into the following groups: sham-
operated gerbils (sham group), vehicle-treated ischemia gerbils
(vehicle-ischemia group) and EAKS (25 and 50 mg/kg)-treated
ischemia gerbils (EAKS-ischemia group). EAKS was orally
administered through a feeding needle once a day for 7
days before transient ischemia, and the last treatment was
30 min before ischemia/reperfusion. Because in traditional
medicine EAKS is taken orally and there are no data about
the absorption and metabolism of EAKS (Yang et al, 2009),
we selected oral administration of 50 mg/kg EAKS.
Gerbils underwent transient cerebral ischemia as in our
previous study (Ahn et al, 2009). Briefly, the animals were
anesthetized. Bilateral common carotid arteries were occluded
for 5 minutes. The rectal temperature was monitored and
maintained (37±0.5
oC) before, during and after the surgery.
Sham-operated animals were subjected to the same surgical
procedures except that the common carotid arteries were
not occluded.
To elucidate the protective effects of EAKS, brain sections
from each group (n=7 in each group) were prepared at 4
days post-ischemia and stained with cresyl violet as we
previously described. Cresyl violet-positive cells were counted
using an image analyzing system (software: Optimas 6.5,
Figure 1. Cresyl violet staining in the hippocampus of sham (A, E), vehicle-ischemia (B, F), 25 mg EAKS-ischemia (C, G) and 50
mg EAKS-ischemia (D, H) group at 4 days post-ischemia. In the vehicle-ischemia and 25 mg EKAS-ischemia groups, only a few
neurons in CA1 region (asterisk) are stained; in the 50 mg EAKS-ischemia group, many cresyl violet-positive cells are found. CA1,
cornu ammonis 1; CA2/3, cornu ammonis 2/3; DG, dentate gyrus; SO, stratum oriens; SP, stratum pyramidale; SR, stratum
radiatum. Scale bar=400 µm (A, B, C and D), 50 ìm (E, F, G and H). I: Relative number of cresyl violet-positive neurons in each
group (n=7 per group; *P<0.05, significantly different from the sham group). Bars indicate mean±SD.Effect of EAKS against ischemic damage 69
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CyberMetrics, Scottsdale, USA) (Choi et al, 2009a). We also
examined the effect of brain-derived neurotrophic factor
(BDNF) on ischemic damage at sham, 2 and 4 days post-
ischemia (n=7 in each group) through immunochemistry using
rabbit anti-BDNF (1:1,000; Chemicon International, Temecula,
CA, USA) (Kim et al, 2007). In addition, we examined BDNF
levels in the ischemic CA1 region of animals (n=5 in each
group) through western blot analysis (Kim et al, 2007). The
relative number of positive cells and the relative optical density
of the bands of the Western blot analysis were shown as
% of the sham group.
Data are expressed as the mean±SD. The data were
evaluated by one-way ANOVA (SPSS program), and the means
assessed using Duncan's multiple-range test. Statistical
significance was considered at P<0.05.
Results
In the sham group, neurons in the hippocampus were
well stained with cresyl violet (Figures 1A and 1E). Delayed
neuronal death in the hippocampal CA1 region was observed
in the vehicle-ischemia group 4 days after ischemia/reperfusion
(Figures 1B and 1F): About 13.8% of CA1 neurons were
stained with cresyl violet (Figure 1I). In the 25 mg/kg EAKS-
ischemia group, cresyl violet-positive cells were similar to those
in the vehicle-ischemia group (Figures 1C, 1G and 1I).
However, many neurons (about 67% of CA1 neurons) were
well stained with cresyl violet in the 50 mg/kg EAKS-treated
group (Figures 1D, 1H and 1I).
Change in BDNF immunoreactivity was well detected in
the CA1 region of the vehicle-ischemia group (Figures 2A,
Figure 2. Immunohistochemistry for BDNF in the CA1 region in the sham (A, B), vehicle-ischemia and 50 mg EAKS-ischemia
groups at 3 hours (C, D), 12 hours (E, F), 2 days (G, H) and 4 days (I, J) post-ischemia. BDNF immunoreactivity in the stratum
pyramidale (SP) is gradually decreased with time; however, in the EAKS-ischemia group, BDNF immunoreactivity (asterisk) is
maintained in pyramidal cells. SO, stratum oriens; SR, stratum radiatum. Scale bar=50 µm.70 Hua Li et al
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2C, 2E, 2G and 2I). In the vehicle-sham group, strong BDNF
immunoreactivity was detected in the stratum pyramidale
(Figure 1A). At 3 hours after ischemic insult, BDNF
immunoreactivity was significantly decreased in the vehicle-
ischemia group (Figure 2C). Thereafter, BDNF immuno-
reactivity gradually decreased with time and was hardly
detected at 4 days post-ischemia (Figures 2E, 2G and 2I).
In each EAKS-ischemia group, BDNF immunoreactivity was
significantly higher than in each vehicle-ischemia group (Figures
2D, 2F, 2H and 2J): the BDNF immunoreactivity was
maintained in the stratum pyramidale of the CA1 region after
50 mg/kg EAKS treatment. 
Western blot analysis also showed a similar change in BDNF
levels in the vehicle-ischemia group compared to the
immunohistochemical findings after ischemia/reperfusion
(Figure 3): BDNF level in the vehicle-ischemia group was
lowest at 4 days post-ischemia. In the 50 mg/kg EAKS-ischemia
group, BDNF levels were higher than in the vehicle-ischemia
group, showing levels that were similar to those in the EAKS-
sham group.
Discussion
 Interestingly, extracts from natural substances have the ability
to protect neurons from ischemic damage (Chun et al, 2008;
Nazam Ansari et al, 2008; Yoo et al, 2010). The extracts
have several functions including antioxidant effects in the
neuroprotection from ischemic insults.
The administration of 50 mg/kg EAKS to gerbil protected
the CA1 pyramidal neurons from ischemic damage: about
67% of the CA1 pyramidal neurons survived after transient
ischemic insults. This is the first report to show that EAKS
has neuroprotective effects in a gerbil model of ischemic
damage. This finding is supported by a previous study in
which EAKS inhibited H2O2-induced apoptosis and enhanced
the viability of Chinese hamster lung fibroblasts (V79-4) (Lee
et al, 2003).
The results of this study show that the EAKS-treated group
had significantly increased BDNF immunoreactivity in the
CA1 region after 12 hours post-ischemia compared to the
vehicle-treated group. BDNF, a neurotrophic factor, has been
associated with neuronal survival, synaptic plasticity, learning
and memory, as well as neuronal plasticity (Miller and Kaplan,
2001; Ploughman et al, 2009). It has been reported that
intraventricular treatment with BDNF reduced neuronal
apoptosis induced by ischemia, suggesting that its effect is
correlated with phosphorylation of Akt (Han and Holtzman,
2000). In addition, BDNF treatment prevented arabinoside-
induced apoptosis in cultured cerebellar granular cells and
glutamate-induced apoptosis in hippocampal neurons by
increasing Akt and Bcl-2 levels (Almeida et al, 2005; Leeds
et al, 2005).
Figure 3. Western blot analysis of BDNF in the CA1 region of the sham, vehicle-ischemia and 50 mg EAKS-ischemia groups.
Relative optical density (ROD) as a percentage of the immunoblot band is presented (n=5 per group; *P<0.05, significantly different
from the sham group; 
#P<0.05, significantly different from the preceding group;
 †P<0.05, significantly different from the vehicle-
ischemia group). Bars indicate mean±SD.Effect of EAKS against ischemic damage 71
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In conclusion, the findings of the present study demonstrate
that repeated oral administration of EAKS protects neurons
from ischemic damage in the hippocampus in a gerbil model
of transient cerebral ischemia, and indicate that the effect
might be associated with an upregulation of BDNF, a
neurotrophic factor.
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